Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12122788 Process of making CFTR modulators

Patent 12122788 was granted and assigned to Vertex Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Vertex Pharmaceuticals

0

Current Assignee

Vertex Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

John E. Cochran0

Mark Thomas Miller0

Corey Don Anderson0

Timothy Richard Coon0

Fabrice Pierre0

Armando Urbina0

Benjamin J. Littler0

Peter Grootenhuis0

...

Date of Patent

October 22, 2024

0

Patent Application Number

180931420

Date Filed

January 4, 2023

0

Patent Citations

US Patent 9981910 Substituted pyrrolidines and methods of use

0

US Patent 8865902 Deuterated CFTR potentiators

0

US Patent 9663508 Biaryl acyl-sulfonamide compounds as sodium channel inhibitors

0

US Patent 9782408 Modulators of cystic fibrosis transmembrane conductance regulator

0

US Patent 10118916 Modulators of cystic fibrosis transmembrane conductance regulator protein

0

US Patent 10131670 Bicyclic heteroaryl derivatives as CFTR potentiators

0

US Patent 10138227 Heteroaryl substituted pyridines and methods of use

0

US Patent 10208053 Bicyclic heteroaryl derivatives as CFTR potentiators

0

...

Patent Primary Examiner

Samantha L Shterengarts

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12122788 Process of making CFTR modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool